KIR3DL2 is expressed in up to 50% of patients with mycosis fungoides and peripheral T-cell lymphoma (PTCL). It has a restricted expression on normal tissues. Lacutamab has been granted European ...

In addition, interferon-a can be used intralesionally for heavily infiltrated lesions of patients with mycosis fungoides. IA: <10% body surface area involved, flat or slightly raised skin lesions ...

In a recent Q&A hosted by Susan Thornton, CEO of the Cutaneous Lymphoma Foundation, a patient advocacy group, Dr. Kim shared her gratitude to clinical trial participants and emphasized the urgent need ...

DelveInsight’s, “Diffuse Large B-Cell Lymphoma Pipeline Insight 2025” report provides comprehensive insights about 70+ ...

Seán MacMahon passed away far too soon at the age of 61 on November 26 2023. He enriched countless lives with his compassion, ...

Citius Oncology inks distribution services agreement with Cardinal Health: Cranford, New Jersey Wednesday, June 11, 2025, 11:00 Hrs [IST] Citius Oncology, Inc. (Citius Oncology), ...

The inflammation and abnormal scaling, flaking, and cracking of the upper layers of the skin in patients with CTCL leads to considerable itching and discomfort. Generally this can be controlled ...

Receiving a thumbs-down from the CHMP were 4SC’s Kinselby, for the treatment of advanced stage mycosis fungoides and Sezary syndrome, and Fresenius Kabi’s Atropine sulfate for children with ...

Blastomycosis — also known as blasto, North American blastomycosis, or Gilchrist disease — is a rare infection caused by breathing in a fungus called blastomyces. It usually affects the lungs ...